Lexicon Pharmaceuticals Azioni (NASDAQ: LXRX)

Lexicon Pharmaceuticals (NASDAQ:LXRX) Azioni, Quote.MetaTitle.unusual-options

Lexicon Pharmaceuticals

Lexicon Pharmaceuticals, Inc. - Common Stock

Lexicon Pharmaceuticals Inc

Alumis

Alto Neuroscience

Aquestive Therapeutics, Inc. - Common Stock

Aquestive Therapeutics

Arvinas

Canopy Growth Corporation - Common Shares

Canopy Growth

Cormedix

Cronos Group

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Cybin

Evolus

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Eton Pharmaceuticals, Inc. - Common Stock

Eton Pharmaceuticals

EyePoint Pharmaceuticals, Inc. - Common Stock

EyePoint Pharmaceuticals

Fulcrum Therapeutics, Inc. - Common Stock

Fulcrum Therapeutics

GH Research

LB Pharmaceuticals

LENZ Therapeutics

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

Omeros

Septerna

SIGA Technologies

SNDL

Theravance Biopharma, Inc. - Ordinary Shares

Theravance Biopharma

Ventyx Biosciences

Zevra Therapeutics

Lexicon Pharmaceuticals (LXRX) Previsione

Notizie

Utili

Quote.Nav.option-chain

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, also developing LX9851, an orally-delivered small molecule drug candidate, as a treatment for obesity and associated cardiometabolic.

Comments

Lexicon Pharmaceuticals Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO